Valneva

Valneva Receivables

The Accounts Receivable of Valneva (VLA.PA) as of Oct 31, 2026 is 35.21 M EUR. In the previous year, Accounts Receivable was 41.65 M EUR — a change of -15.46% (lower).

Receivables

35.21 MEUR

YoY

-15.46%

Last updated:

Accounts Receivable of Valneva is 2024 35.21 M EUR. Accounts Receivable of Valneva was 2023 41.65 M EUR. It decreases by -15.46% lower compared to the previous year.

The Valneva Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
17.62 M EUR
Jan 1, 2018
11.26 M EUR
Jan 1, 2019
24.03 M EUR
Jan 1, 2020
19.23 M EUR
Jan 1, 2021
44.01 M EUR
Jan 1, 2022
23.91 M EUR
Jan 1, 2023
41.65 M EUR
Jan 1, 2024
35.21 M EUR
The Valneva Receivables history
YEARReceivablesYoY
35.21 MEUR-15.46%
41.65 MEUR+74.16%
23.91 MEUR-45.67%
44.01 MEUR+128.85%
19.23 MEUR-19.97%
24.03 MEUR+113.43%
11.26 MEUR-36.11%
17.62 MEUR+4.20%
16.91 MEUR+7.35%
15.75 MEUR+129.99%
6.85 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Accounts Receivable of Valneva is 35.21 M EUR in 2024.

Accounts Receivable of Valneva changed from 41.65 M EUR to 35.21 M EUR, representing a -15.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Valneva since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Valneva historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Valneva

All Key Metrics — Valneva